Our findings in clinical specimens and HCC cell lines established a critical role of TARBP2 in the progression of HCC, suggested a potential linkage between the molecular levels of TARBP2 and the clinical outcomes in HCC. Here, TARBP2 is linked to hepatocellular carcinoma.